Device Trial Radar · NCT01811446
Evaluation of Muscle Activation Efficiency in Challenging Subjects
Last checked: Nov 20, 2026Latest source record: Jan 31, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Niveus Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 14, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether muscle activation can be accomplished more effectively and comfortably in challenging subjects using novel configurations of an activation device. A novel device will be compared side by side with a market leading device.
Conditions
- Obesity
- COPD
Interventions
Muscle Activation with Niveus and Intelect DevicesDevice
Subjects will receive muscle activation technology from the Niveus device on one leg and from the Intelect (commercially-available third-party) device on the other. The order of use and the leg applied to will be randomized.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Intensity RequiredTime frame: During treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fogarty Clinical Research
Mountain View, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.